M.S.M. Alayat, E.M. Abdel-Kafy, A.A.M. Thabet, A.S. Abdel-Malek, T. H. Ali, E.A. Header
Photomedicine and Laser Surgery, DOI: 10.1089/PHO.2017.4328, 2017
Background: A pulsed Nd-YAG laser is an effective physiotherapy modality used as a class IV high-intensity laser therapy (HILT).
Purpose: The aim of this study is to investigate the efficacy of HILT alone or combined with exercise (HILT+EX) on bone mineral density (BMD) after 24 weeks and at 1 year of follow-up in men with osteopenia or osteoporosis.
Methods: One hundred men with osteopenia or osteoporosis (mean age, 53.78 [2.89] years; weight, 80.56 [7.33] kg; height 175 [5.30] cm) participated in the study. The T-scores were ≤-1.5. Patients were randomly assigned to four groups: HILT+EX (group I), placebo laser plus exercise (PL+EX; group II), HILT alone (HILT; group III), and PL (group IV). HILT was applied to the lower back and hip regions. Aerobic, weight-bearing, flexibility, strengthening, and balance exercises were performed three times per week for 24 weeks. The measured outcomes were BMD of the L2-L4 spine and total hip. Measurements were taken before and after 24 weeks and at 1 year of follow-up.
Results: Lumbar and total hip BMD significantly increased post-treatment in the HILT+EX and PL+EX groups, but insignificantly in the HILT and PL groups. HILT+EX showed a significantly greater effect than PL+EX did on lumbar BMD, with no significant difference in total hip BMD, after 24 weeks and at follow-up.
Conclusion: Although HILT alone did not effectively increase lumbar and total hip BMD, HILT combined with exercise was more effective than exercise alone at increasing lumbar BMD after 24 weeks of treatment, with effects lasting up to 1 year.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.